Loading...
First Trust Nasdaq Pharmaceuticals ETF
FTXH•NASDAQ
Financial ServicesAsset Management
$25.41
$0.89(3.61%)
First Trust Nasdaq Pharmaceuticals ETF (FTXH) Stock Overview
Explore First Trust Nasdaq Pharmaceuticals ETF’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for FTXHStats details for FTXH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for FTXHAnalyst Recommendations details for FTXH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
Headquarters
MA
Founded
2016